Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-091983 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
63,458
Total Value
$916,668.61
P&L
+inf% (+$4,125,334.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Grant/Award | 17,650 | $0.00 | $0.00 | 127,642 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 1,510 | $87.75 | $132,503.86 | 126,132 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 1,055 | $88.50 | $93,367.92 | 125,077 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 3,048 | $89.66 | $273,275.76 | 122,029 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 492 | $84.00 | $41,326.28 | 121,537 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 2,519 | $85.04 | $214,206.69 | 119,018 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 1,437 | $85.78 | $123,266.87 | 117,581 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 447 | $86.62 | $38,721.24 | 117,134 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Grant/Award | 35,300 | $0.00 | $0.00 | 35,300 | Direct | โ | View Details |